PEOPLE - Vascular Solutions (US) makes appointment:
This article was originally published in Clinica
Vascular Solutions, a US developer of vascular sealing devices, has named Charmaine Sutton vice-president of regulatory affairs. Ms Sutton has provided consulting services to the company since its inception.
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.